Targeting HLA-DR

被引：1

作者：

Tay, Kevin ^{[1
]}

Dunleavy, Kieron ^{[1
]}

Wilson, Wyndham H. ^{[1
]}

机构：

[1] NCI, Ctr Canc Res, Metab Branch, Bethesda, MD 20892 USA

来源：

LEUKEMIA & LYMPHOMA | 2009年 / 50卷 / 12期

关键词：

CHRONIC LYMPHOCYTIC-LEUKEMIA; HU1D10; ANTIBODY; ANTIGEN; CELLS;

D O I：

10.3109/10428190903370379

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1911 / 1913

页数：3

共 14 条

[1]

ALTOMONTE M, 1993, J IMMUNOL, V151, P5115

[2] Mitochondria control of cell death induced by anti-HLA-DR antibodies [J].

Bains, SK ;

Mone, A ;

Tso, JY ;

Lucas, D ;

Byrd, JC ;

Weiner, GJ ;

Green, JM .

LEUKEMIA, 2003, 17 (07) :1357-1365

[3]

Dunleavy K, 2005, J CLIN ONCOL, V23, p586S

[4]

GINGRICH RD, 1990, BLOOD, V75, P2375

[5] Pattern of graft- and host-specific MHC class II expression in long-term murine cardiac allografts - Origin of inflammatory and vascular wall cells [J].

Hasegawa, S ;

Becker, G ;

Nagano, H ;

Libby, P ;

Mitchell, RN .

AMERICAN JOURNAL OF PATHOLOGY, 1998, 153 (01) :69-79

[6] GROWTH-INHIBITION OF EPSTEIN-BARR VIRUS-TRANSFORMED B-CELLS BY ANTI-HLA-DR ANTIBODY L243 - POSSIBLE RELATIONSHIP TO L243-INDUCED DOWN-REGULATION OF CD23 ANTIGEN EXPRESSION [J].

KABELITZ, D ;

JANSSEN, O .

CELLULAR IMMUNOLOGY, 1989, 120 (01) :21-30

[7] Humanization and characterization of the anti-HLA-DR antibody 1D10 [J].

Kostelny, SA ;

Link, BK ;

Tso, JY ;

Vasquez, M ;

Jorgensen, BH ;

Wang, H ;

Hall, WC ;

Weiner, GJ .

INTERNATIONAL JOURNAL OF CANCER, 2001, 93 (04) :556-565

[8] A phase I/II dose escalation study of apolizumab (Hu1D10) using a stepped-up dosing schedule in patients with chronic lymphocytic leukemia and acute leukemia [J].

Lin, Thomas S. ;

Stock, Wendy ;

Xu, Huiping ;

Phelps, Mitch A. ;

Lucas, Margaret S. ;

Guster, Sara K. ;

Briggs, Bruce R. ;

Cheney, Carolyn ;

Porcu, Pierluigi ;

Flinn, Ian W. ;

Grever, Michael R. ;

Dalton, James T. ;

Byrd, John C. .

LEUKEMIA & LYMPHOMA, 2009, 50 (12) :1958-1963

[9]

Link BK, 2001, BLOOD, V98, p606A

[10]

LINK BK, 2001, P AN M AM SOC CLIN, V20, P1135

← 1 2 →